COMPLETED

The Acupuncture for Pain, Opioid Use Disorder and Mood

Conditions

Chronic Pain Opioid Use Disorder Mood Change Opioid Misuse Opioid-Related Disorders Acupuncture

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this study is to determine how patients with chronic pain and opioid use disorder will respond to treatment with acupuncture, including whether there will be any changes in mood (as an exploratory outcome). Results from this study have the potential to inform future studies in patients who would consider using acupuncture as an intervention for their conditions.

Official Title

The Acupuncture for Pain, Opioid Use Disorder and Mood (AcuPOM) Study: A Pilot Trial

Quick Facts

Study Start:2025-01-06

Study Completion:2025-06-04

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:COMPLETED

Study ID

NCT06543355

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
1. ≥18 years old, 2. English proficiency; 3. receiving methadone treatment at an OTP through the Montefiore network for at least 12 weeks, with no dose change in 14 days to ensure treatment stability; 4. chronic pain of at least moderate pain severity (score of at least 4 on the Pain, Enjoyment of Life and General Activity (PEG) scale); 5. willingness to participate in all study components; and 6. ability to provide informed consent	1. Have pending surgery or invasive pain management procedure; 2. Have a pending or planned relocation; 3. have an acutely or exacerbation of psychotic, suicidal, or homicidal conditions that preclude the ability to participate; and 4. pregnancy

Inclusion Criteria

Exclusion Criteria

1. ≥18 years old,
2. English proficiency;
3. receiving methadone treatment at an OTP through the Montefiore network for at least 12 weeks, with no dose change in 14 days to ensure treatment stability;
4. chronic pain of at least moderate pain severity (score of at least 4 on the Pain, Enjoyment of Life and General Activity (PEG) scale);
5. willingness to participate in all study components; and
6. ability to provide informed consent

1. Have pending surgery or invasive pain management procedure;
2. Have a pending or planned relocation;
3. have an acutely or exacerbation of psychotic, suicidal, or homicidal conditions that preclude the ability to participate; and
4. pregnancy

Contacts and Locations

Principal Investigator

Jessica Bayner, MD

PRINCIPAL_INVESTIGATOR

Montefiore Medical Center

Study Locations (Sites)

Montefiore Division of Substance Abuse (DoSA) Wellness Center at Melrose

The Bronx, New York, 10451

United States

Collaborators and Investigators

Sponsor: Albert Einstein College of Medicine

Jessica Bayner, MD, PRINCIPAL_INVESTIGATOR, Montefiore Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-06

Study Completion Date2025-06-04

Study Record Updates

Study Start Date2025-01-06

Study Completion Date2025-06-04

Terms related to this study

Keywords Provided by Researchers

Acupuncture

Additional Relevant MeSH Terms

Chronic Pain
Opioid Use Disorder
Mood Change
Opioid Misuse
Opioid-Related Disorders